{"id":"W2599055371","doi":"10.1200/jco.2013.31.15_suppl.5541","title":"Feasibility and safety of front-line bevacizumab (BEV)-containing therapy after neoadjuvant (NA) chemotherapy (CT) for ovarian cancer (OC): The ROSiA experience.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Baker Hughes (Canada)","funders":"","keywords":"Medicine; Bevacizumab; Ovarian cancer; Carboplatin; Surgery; Debulking; Internal medicine; Ovarian carcinoma; Perforation; Chemotherapy; Oncology; Cancer; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002928331,0.0002867797,0.0003444139,0.0001448379,0.000159422,0.0006786881,0.0003676451,0.00034353,0.001435886],"category_scores_gemma":[0.003466502,0.0001693001,0.0006859662,0.0001460052,0.0002877374,0.0004414736,0.0003641993,0.0007163163,0.0004322852],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008482598,"about_ca_system_score_gemma":0.0007783789,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006736668,"about_ca_topic_score_gemma":0.001081808,"domain_scores_codex":[0.9990997,0.0005490694,0.00004717711,0.000105714,0.0001147592,0.00008348298],"domain_scores_gemma":[0.9988925,0.0003531673,0.0003486365,0.0001203596,0.0000448633,0.0002404968],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1603758,0.01312461,0.2019729,0.0008116715,0.00127711,0.0007769056,0.0006850501,0.003806716,0.02590853,0.0008113945,0.006823774,0.5836256],"study_design_scores_gemma":[0.031166,0.4628469,0.4516986,0.0002571358,0.001862903,0.003693844,0.0003273531,0.00677514,0.008910834,0.000667806,0.03171751,0.00007589706],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916596,0.003846585,0.0006934545,0.0004119454,0.00004200328,0.0002334347,0.0003366517,0.00001859671,0.002757723],"genre_scores_gemma":[0.9958938,0.00152828,0.0009333219,0.000350704,0.00008504612,0.0001266147,0.0006003419,0.000009435979,0.0004725253],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002928331,"threshold_uncertainty_score":0.01548666,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1158055236274704,"score_gpt":0.4503666320694562,"score_spread":0.3345611084419858,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}